bpc-157 laboratory peptide – Research BPC-157 Peptide (≥98% Purity) –

This helps equalize the pressure inside the vial, facilitating easier withdrawal of the liquid

And the third included those without enough supporting information for the FDA to make an informed decision and therefore wouldnt be used for compounding

Another commenter stated that, per the criteria described at 419.66(c), CMS has previously established this device category in the CY 2023 OPPS/ASC final rule with comment period

The strongest preclinical evidence supports BPC-157 use for tendon and ligament repair, gut-lining integrity in NSAID-related damage, and inflammation reduction in musculoskeletal tissues

### AOD-9604 Mechanism of Action AOD-9604 is believed to promote **fat loss** through: - Stimulation of lipolysis in adipose tissue via beta-3 adrenergic receptor pathways - Inhibition of lipogenesis (new fat formation) - No effect on growth hormone receptors (does not promote tissue growth) - No effect on IGF-1 levels or blood glucose Importantly, AOD-9604 does **not** suppress appetite or affect food intake it is purely a lipolytic **fat loss peptide**

No regulatory body has cleared it for any medical use